Article
Muscular dystrophies due to glycosylation defects.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics - 1 Oct 2008
Muntoni Francesco, Torelli Silvia, Brockington Martin
Abstract excerpt
In the last few years, muscular dystrophies due to reduced glycosylation of alpha-dystroglycan (ADG) have emerged as a common group of conditions, now referred to as dystroglycanopathies. Mutations in six genes (POMT1, POMT2, POMGnT1, Fukutin, FKRP and LARGE) have so far been identified in patients with a dystroglycanopathy. Allelic mutations in each of these genes can result in a wide spectrum of clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
